Premium
CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis
Author(s) -
Zaldivar Mirko Moreno,
Pauels Katrin,
von Hundelshausen Philipp,
Berres MarieLuise,
Schmitz Petra,
Bornemann Jörg,
Kowalska M. Anna,
Gassler Nikolaus,
Streetz Konrad L.,
Weiskirchen Ralf,
Trautwein Christian,
Weber Christian,
Wasmuth Hermann E.
Publication year - 2010
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.23435
Subject(s) - thioacetamide , fibrosis , chemokine , liver injury , hepatic stellate cell , platelet activation , biology , pathology , chemistry , inflammation , immunology , platelet , endocrinology , medicine
Liver fibrosis is a major cause of morbidity and mortality worldwide. Platelets are involved in liver damage, but the underlying molecular mechanisms remain elusive. Here, we investigate the platelet‐derived chemokine (C‐X‐C motif) ligand 4 (CXCL4) as a molecular mediator of fibrotic liver damage. Serum concentrations and intrahepatic messenger RNA of CXCL4 were measured in patients with chronic liver diseases and mice after toxic liver injury. Platelet aggregation in early fibrosis was determined by electron microscopy in patients and by immunohistochemistry in mice. Cxcl4 −/− and wild‐type mice were subjected to two models of chronic liver injury (CCl 4 and thioacetamide). The fibrotic phenotype was analyzed by histological, biochemical, and molecular analyses. Intrahepatic infiltration of immune cells was investigated by fluorescence‐activated cell sorting, and stellate cells were stimulated with recombinant Cxcl4 in vitro . The results showed that patients with advanced hepatitis C virus–induced fibrosis or nonalcoholic steatohepatitis had increased serum levels and intrahepatic CXCL4 messenger RNA concentrations. Platelets were found directly adjacent to collagen fibrils. The CCl 4 and thioacetamide treatment led to an increase of hepatic Cxcl4 levels, platelet activation, and aggregation in early fibrosis in mice. Accordingly, genetic deletion of Cxcl4 in mice significantly reduced histological and biochemical liver damage in vivo , which was accompanied by changes in the expression of fibrosis‐related genes ( Timp‐1 [tissue inhibitor of matrix metalloproteinase 1], Mmp9 [matrix metalloproteinase 9], Tgf ‐β [transforming growth factor beta], IL10 [interleukin 10]). Functionally, Cxcl4 −/− mice showed a strongly decreased infiltration of neutrophils (Ly6G) and CD8 + T cells into the liver. In vitro , recombinant murine Cxcl4 stimulated the proliferation, chemotaxis, and chemokine expression of hepatic stellate cells. Conclusion: The results underscore an important role of platelets in chronic liver damage and imply a new target for antifibrotic therapies. (H EPATOLOGY 2010.)